Live Breaking News & Updates on Delap Wealth Advisory

Stay updated with breaking news from Delap wealth advisory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tripadvisor, Inc. (NASDAQ:TRIP) Given Average Rating of "Hold" by Brokerages

Shares of Tripadvisor, Inc. (NASDAQ:TRIP – Get Free Report) have received a consensus recommendation of “Hold” from the eighteen analysts that are covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and five have issued a buy recommendation on the company. […] ....

United States , Tripadvisor Inc , Delap Wealth Advisory , Jpmorgan Chase Co , Tidal Investments , Get Free Report , Marketbeat Ratings , Capital Management , Wealth Advisory , Get Free , Brand Tripadvisor , Tripadvisor Daily ,

Playtika Holding Corp. (NASDAQ:PLTK) Receives $10.30 Consensus Target Price from Brokerages

Shares of Playtika Holding Corp. (NASDAQ:PLTK – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eleven brokerages that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to […] ....

United States , Robertw Baird , Banque Cantonale Vaudoise , Stifel Nicolaus , Gili Brudno , Skandinaviska Enskilda Banken , Quent Capital , Playtika Holding Corp , International Assets Investment Management , Morgan Stanley , Goldman Sachs Group , Delap Wealth Advisory , Playtika Holding , Get Free Report , Enskilda Banken , Assets Investment Management , Cantonale Vaudoise , Get Free , Holding Corp , Middle East , Playtika Daily ,

Atara Biotherapeutics (NASDAQ:ATRA) Given Neutral Rating at HC Wainwright

HC Wainwright reaffirmed their neutral rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. HC Wainwright also issued estimates for Atara Biotherapeutics’ Q2 2024 earnings at $0.06 EPS, Q3 2024 earnings at ($0.28) EPS, Q4 2024 earnings at ($0.28) EPS, FY2024 earnings […] ....

United States , Anhco Nguyen , Pascal Touchon , Harbor Capital Advisors Inc , Atara Biotherapeutics Inc , Vontobel Holding Ltd , Advisor Group , Josh Arnold Investment Consultant , Atara Biotherapeutics Company Profile , Delap Wealth Advisory , Free Report , Get Free Report , Wealth Advisory , Arnold Investment Consultant , Harbor Capital Advisors , Capital Advisors ,

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Expected to Post Q1 2025 Earnings of ($0.27) Per Share

Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Atara Biotherapeutics in a research note issued on Wednesday, May 22nd. HC Wainwright analyst R. Burns expects that the biotechnology company will post earnings of ($0.27) per share for the quarter. […] ....

United States , Anhco Nguyen , Pascal Touchon , Advisor Group , Atara Biotherapeutics Company Profile , Securities Exchange Commission , Harbor Capital Advisors Inc , Delap Wealth Advisory , Vontobel Holding Ltd , Atara Biotherapeutics Inc , Free Report , Get Free Report , Exchange Commission , Wealth Advisory , Capital Advisors , Financial Markets ,